Literature DB >> 7882380

Anti-CD30 immunotoxins with native and recombinant dianthin 30.

A Bolognesi1, P L Tazzari, G Legname, F Olivieri, D Modena, R Conte, F Stirpe.   

Abstract

Immunotoxins were prepared with a Ber-H2 (anti-CD30) monoclonal antibody and native or recombinant dianthin 30, a ribosome-inactivating protein from Dianthus caryophyllus (carnation). Both immunotoxins selectively inhibited protein synthesis by CD30+ cell lines D430B (lymphoblastoid, infected with Epstein-Barr virus), L428 and L540 (both from Hodgkin's lymphoma). IC50 values (concentrations, as dianthin, causing 50% inhibition) ranged from 324 pM to 479 pM (immunotoxin with native dianthin 30) or from 45 pM to 182 pM (immunotoxin with recombinant dianthin 30). The effect of either immunotoxin on protein synthesis by the CD30+ cell line K562 (from a chronic myeloid leukaemia) was not different from that of free dianthin (IC50 higher than nM).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7882380     DOI: 10.1007/bf01520292

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  21 in total

1.  Ber-H2 (anti-CD30)-saporin immunotoxin: a new tool for the treatment of Hodgkin's disease and CD30+ lymphoma: in vitro evaluation.

Authors:  P L Tazzari; A Bolognesi; D de Totero; B Falini; R M Lemoli; M R Soria; S Pileri; M Gobbi; H Stein; L Flenghi
Journal:  Br J Haematol       Date:  1992-06       Impact factor: 6.998

Review 2.  Structural factors influencing the pharmacokinetics and stability of immunotoxins.

Authors:  E J Wawrzynczak; A J Cumber; R V Henry; G D Parnell; J H Westwood
Journal:  Biochem Soc Trans       Date:  1992-11       Impact factor: 5.407

3.  Distribution and properties of major ribosome-inactivating proteins (28 S rRNA N-glycosidases) of the plant Saponaria officinalis L. (Caryophyllaceae).

Authors:  J M Ferreras; L Barbieri; T Girbés; M G Battelli; M A Rojo; F J Arias; M A Rocher; F Soriano; E Mendéz; F Stirpe
Journal:  Biochim Biophys Acta       Date:  1993-10-19

4.  Evaluation of ricin A chain-containing immunotoxins directed against the CD30 antigen as potential reagents for the treatment of Hodgkin's disease.

Authors:  A Engert; F Burrows; W Jung; P L Tazzari; H Stein; M Pfreundschuh; V Diehl; P Thorpe
Journal:  Cancer Res       Date:  1990-01-01       Impact factor: 12.701

5.  A Saporin-6 cDNA containing a precursor sequence coding for a carboxyl-terminal extension.

Authors:  L Benatti; G Nitti; M Solinas; B Valsasina; A Vitale; A Ceriotti; M R Soria
Journal:  FEBS Lett       Date:  1991-10-21       Impact factor: 4.124

Review 6.  Immunotoxins: magic bullets or misguided missiles?

Authors:  E S Vitetta; P E Thorpe; J W Uhr
Journal:  Immunol Today       Date:  1993-06

7.  Response of refractory Hodgkin's disease to monoclonal anti-CD30 immunotoxin.

Authors:  B Falini; A Bolognesi; L Flenghi; P L Tazzari; M K Broe; H Stein; H Dürkop; F Aversa; P Corneli; G Pizzolo
Journal:  Lancet       Date:  1992-05-16       Impact factor: 79.321

8.  Dianthins, ribosome-damaging proteins with anti-viral properties from Dianthus caryophyllus L. (carnation).

Authors:  F Stirpe; D G Williams; L J Onyon; R F Legg; W A Stevens
Journal:  Biochem J       Date:  1981-05-01       Impact factor: 3.857

9.  Expression and activity of pre-dianthin 30 and dianthin 30.

Authors:  G Legname; G Gromo; J M Lord; N Monzini; D Modena
Journal:  Biochem Biophys Res Commun       Date:  1993-05-14       Impact factor: 3.575

10.  Recognition and killing of tumour cells expressing heat shock protein 65 kD with immunotoxins containing saporin.

Authors:  F Poccia; P Piselli; S Di Cesare; S Bach; V Colizzi; M Mattei; A Bolognesi; F Stirpe
Journal:  Br J Cancer       Date:  1992-09       Impact factor: 7.640

View more
  5 in total

Review 1.  Targeting CD30 in anaplastic large cell lymphoma.

Authors:  Joseph Vadakara; Barbara Pro
Journal:  Curr Hematol Malig Rep       Date:  2012-12       Impact factor: 3.952

2.  Constitutive overexpression of a novel 21 kDa protein by Hodgkin lymphoma and aggressive non-Hodgkin lymphomas.

Authors:  Minglong Zhou; Faisal M Fadlelmola; Jason B Cohn; Brian Skinnider; Randy D Gascoyne; Diponkar Banerjee
Journal:  Mol Cancer       Date:  2008-01-24       Impact factor: 27.401

Review 3.  Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy.

Authors:  Roger Gilabert-Oriol; Alexander Weng; Benedicta von Mallinckrodt; Matthias F Melzig; Hendrik Fuchs; Mayank Thakur
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 4.  Hyperuricaemia, Xanthine Oxidoreductase and Ribosome-Inactivating Proteins from Plants: The Contributions of Fiorenzo Stirpe to Frontline Research.

Authors:  Andrea Bolognesi; Massimo Bortolotti; Maria Giulia Battelli; Letizia Polito
Journal:  Molecules       Date:  2017-01-27       Impact factor: 4.411

Review 5.  Dianthin and Its Potential in Targeted Tumor Therapies.

Authors:  Hendrik Fuchs
Journal:  Toxins (Basel)       Date:  2019-10-11       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.